The Weston Brain Institute recently launched the Rapid Response Canada 2018 program for Alzheimer’s & Related Diseases. A summary is provided below.
To provide funding for novel, high-risk, high-reward translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.
This call is focused on Alzheimer’s related diseases:
- Alzheimer’s disease
- Frontotemporal dementia
- Mild cognitive impairment
- Vascular contributions to the above
- Prodromes to the above
Projects must meet two conditions to be eligible:
- Be translational research that helps accelerate the development of therapeutics for neurodegenerative diseases of aging
- Be the development of a therapeutic and/or tool
An information webinar will be held on March 8, 2018 at 1:00pm EST. To register for the webinar, please click here.
Up to $200K
Up to 18 months
Submission of Letter of Intent (LOI) to ORS – April 5, 2018
Submission of LOI to agency – April 19, 2018 at 2:00pm EDT
Submission of full proposal to ORS – July 24, 2018
Submission of full proposal to agency (by invitation only) – August 8, 2018 at 2:00pm EDT
For complete details on this opportunity and application process, please click here.
Back to Funding Opportunities